Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Francesc Bosch, Véronique Leblond, Agostino Cortelezzi et al.|Leukemia|2019

Cited by 12